November 11, 2020 | Media Coverage
1st Patient Treated in Phase 3 Trial of RDEB Gene Therapy, D-Fi
Read MoreOctober 29, 2020 | ~Home Feature| Media Coverage
Castle Creek Biosciences’ D-Fi To Be Manufactured At In-House cGMP
Read MoreOctober 28, 2020 | ~Home Feature| Press Release
Company manufacturing and distributing D-Fi at in-house, cGMP commercial-scale facility in greater Philadelphia area
Read MoreOctober 20, 2020 | ~Home Feature| Media Coverage
First Patient Treated in Trial Testing FCX-013 Gene Therapy for Localized Scleroderma
Read MoreOctober 15, 2020 | ~Home Feature| Press Release
Study targets a chronic autoimmune skin disorder affecting approximately 50,000 patients in the U.S.
Read MoreMay 09, 2020 | Media Coverage
9 Philly Companies on the Cutting Edge of Cell and Gene Therapy Innovation
Read More